Valuation: ImmuneOncia Therapeutics, Inc.

Market Cap 224B 154M 136M 127M 116M 218M 14.79B 223M 1.5B 587M 7.32B 580M 567M 25.3B P/E 2024 *
-
P/E 2025 -33.4x
Enterprise Value 201B 138M 122M 113M 104M 195M 13.25B 200M 1.35B 526M 6.56B 519M 508M 22.67B EV / Sales 2024 *
-
EV / Sales 2025 8,473x
Free-Float
46.15%
Yield 2024 *
-
Yield 2025 -
1 day-6.48%
1 week-11.05%
Current month-31.42%
1 month-32.92%
3 months-65.42%
6 months-78.02%
Current year-81.14%
1 week 2,300
Extreme 2300
3,180
1 month 2,300
Extreme 2300
3,665
Current year 2,300
Extreme 2300
14,240
1 year 2,300
Extreme 2300
16,110
3 years 2,300
Extreme 2300
16,110
5 years 2,300
Extreme 2300
16,110
10 years 2,300
Extreme 2300
16,110
Manager TitleAgeSince
Chief Executive Officer 70 21/07/2021
Director of Finance/CFO 55 26/12/2023
Chief Tech/Sci/R&D Officer 51 -
Director TitleAgeSince
Director/Board Member 70 21/07/2021
Director/Board Member 55 26/12/2023
Director/Board Member 69 30/03/2021
Change 5-day change 1-year change 3-year change Capi.($)
-6.48%-11.05%-57.67% - 154M
-2.53%-5.12%+44.53%+65.47% 55.2B
+2.83%+0.48%+28.18%+82.59% 55.6B
+0.54%+1.22%-16.62%-13.47% 23.51B
-0.97%-3.30%-1.79%+383.00% 22.35B
-4.01%-3.67%+13.17%-14.29% 20.6B
-1.51%-3.78%+25.18%-34.27% 17.45B
-3.34%-7.77%+23.78%+536.66% 15.16B
-2.09%+0.64%+49.78%+178.74% 13.91B
-3.14%-8.47%+165.37%+292.18% 13.74B
Average -2.06%-2.77%+27.39%+164.07% 23.77B
Weighted average by Cap. -0.93%-0.53%+32.07%+127.13%

Financials

2024 2025
Net sales 655M 451K 396K 370K 340K 636K 43.21M 651K 4.39M 1.72M 21.38M 1.69M 1.66M 73.92M 111M 76.65K 67.35K 62.87K 57.69K 108K 7.34M 111K 745K 292K 3.63M 288K 282K 12.56M
Net income -5.69B -3.92M -3.44M -3.21M -2.95M -5.52M -375M -5.66M -38.12M -14.91M -186M -14.72M -14.4M -642M -27.36B -18.86M -16.57M -15.47M -14.2M -26.57M -1.81B -27.23M -183M -71.73M -894M -70.81M -69.27M -3.09B
Net Debt -11.23B -7.74M -6.8M -6.35M -5.83M -10.91M -741M -11.18M -75.29M -29.44M -367M -29.06M -28.43M -1.27B -23.37B -16.11M -14.15M -13.21M -12.12M -22.69M -1.54B -23.25M -157M -61.26M -763M -60.47M -59.16M -2.64B
Logo ImmuneOncia Therapeutics, Inc.
ImmuneOncia Therapeutics Inc is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company is principally engaged in the research and development of antibody-based cancer immunotherapy treatments.
Employees
-
Date Price Change Volume
29/07/26 ₩2,455.00 -6.48% 366,690
28/07/26 ₩2,625.00 -6.25% 224,926
27/07/26 ₩2,800.00 -1.75% 176,991
24/07/26 ₩2,850.00 -2.73% 488,706
23/07/26 ₩2,930.00 +6.16% 227,643
  1. Stock Market
  2. Stocks
  3. A424870 Stock